Home / Brands / ACCORD HEALTHCARE
ACCORD HEALTHCARE Recalls
94 recalls on record · February 22, 2017 to July 8, 2026 · Drugs
Recalls by year
17
18
21
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Glimepiride Tablets USP, 1 mg, Rx Only, Packaged in: a) 100-count bottle NDC 16729-001-01 UPC 3 16729 00101 4; b) 500-c
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Finasteride Tablets USP, 5 mg, Rx Only, Packaged as: a) 30-count bottles NDC 16729-090-10 UPC 3 16729 09010 0; b) 90-cou
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Finasteride Tablets USP 1 mg, 90-count bottle, Keeps, Rx Only, Manufactured for: Thirty Madison, Inc. New York, NY 10016
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Finasteride Tablets USP, 1 mg, Rx Only, Packaged as: a) 30-count bottle NDC 16729-089-10 UPC 3 16729 08910 4; b) 90-cou
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Doxazosin Tablets USP, 8 mg, Rx Only, Packaged in: a) 100 Tablets NDC 16729-415-01 UPC 3 16729 41501 9; b) 1,000 Tablets
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Doxazosin Tablets USP, 4 mg, Rx Only, Packaged as: a) 100-count bottle NDC 16729-213-01 UPC 3 16729 21301 1; b) 1,000-co
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Doxazosin Tablets USP, 2 mg, Rx Only, Packaged as: a) 100-count bottle NDC 16729-414-01 UPC 3 16729 41401 2; b) 1,000-co
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Doxazosin Tablets USP 1 mg, Rx Only, Packaged as: a) 100-count bottle NDC 16729-211-01 UPC 3 16729 21101 7; b) 1,000-cou
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Dofetilide Capsules 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Dofetilide Capsules, 125 mcg (0.125 mg), 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Daptomycin for Injection 500 mg per vial, Single-dose vial, Rx only, Manufactured by: Intas Pharmaceuticals Limited, Pha
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Daptomycin for Injection 350 mg/vial, Rx only, Packaged as: a) Single-dose vial NDC 16729-434-05 UPC 3 16729 43405 8; b)
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Clopidogrel Tablets USP, 75 mg, Rx Only, Packaged in a) 30-count bottles NDC 16729-218-10 UPC 3 16729 21810 8; b) 90-co
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls BusPIRone Hydrochloride Tablets USP 30 mg, 60-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham,
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls BusPIRone Hydrochloride Tablets USP, 10 mg 500-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham,
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls BusPIRone Hydrochloride Tablets USP 15 mg, Rx Only, 100-count bottle, Manufactured for: Accord Healthcare, Inc., Durham,
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls BusPIRone Hydrochloride Tablets USP, 5 mg, Rx Only, Packaged as: a) 100 Tablets NDC 16729-200-01 UPC 3 16729 20001 1; b)
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls BusPIRone Hydrochloride Tablets USP 7.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Atorvastatin Calcium Tablets USP 80 mg* Rx Only, Packaged as a) 90 Tablets NDC 16729-047-15 UPC 3 16729 04715 9; b) 500
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Atorvastatin Calcium Tablets USP 40 mg* Rx Only, Packaged as a) 90 Tablets NDC 16729-046-15 UPC 3 16729 04615 2; b) 1,00
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Atorvastatin Calcium Tablets USP 20 mg* Rx Only, Packaged as a) 90 Tablets NDC 16729-045-15 UPC 3 16729 04515 5; b) 1,0
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Atorvastatin Calcium Tablets USP, 10 mg* Rx Only, Packaged as a) 90 Tablets NDC 16729-044-15 UPC 3 16729 04415 8; b) 1,
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Aripiprazole Tablets, USP 30 mg Rx Only, a) 30-count bottle, NDC 16729-283-10, UPC 3 16729 28310 6; b) 100-count bottle
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Aripiprazole Tablets, USP 20 mg Rx Only, packaged as, a) 30-count bottle, NDC 16729-282-10, UPC 3 16729 28210 9; b) 100
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Aripiprazole Tablets, USP 15 mg Rx Only, Packaged as: a) 30-count bottle NDC 16729-281-10, UPC 3 16729 28110 2; b) 100-c
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Aripiprazole Tablets, USP 10 mg Rx Only, Packaged as a) 30-count bottle, NDC 16729-280-10, UPC 3 16729 28010 5; b) 100-c
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Aripiprazole Tablets, USP 5 mg Rx Only, Packaged as a) 30-count bottle, NDC 16729-279-10, UPC 3 16729 27910 9; b) 100-co
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
March 8, 2023DrugsFDA
Accord Healthcare, Inc. recalls Aripiprazole Tablets, USP 2 mg, Rx Only, Packaged as a) 30-count bottle, NDC 16729-278-10, UPC 3 16729 27810 2; b) 100-
Hazard: CGMP Deviations: recalling drug products following an FDA inspection.
February 1, 2023DrugsFDA
Accord Healthcare, Inc. recalls Allopurinol Tablets USP, 100 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703,
Hazard: Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.